EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 374,40 INR
arrow_upward
+1,52%(+35,60) 1D
17-ноя., 11:39:35 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 338,80 INR
High
2 397,50 INR
Low
2 335,20 INR
Mkt. cap
450,45 млд
Avg. vol.
229,17 миң
Volume
82,17 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,84
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
Open
2 338,80 INR
High
2 397,50 INR
Low
2 335,20 INR
Mkt. cap
450,45 млд
Avg. vol.
229,17 миң
Volume
82,17 миң
Dividend
0,15%
Quarterly dividend
0,90 INR
Ex-dividend date
2026-ж., 4-сен.
P/E ratio
49,84
52-wk high
2 429,90 INR
52-wk low
1 312,30 INR
EPS
47,64 INR
No. of employees
7 миң
News stories
From web sources and news partners
TradingView
·
2 саат мурун
Dow, S&P 500, Nasdaq Futures Mixed Ahead Of Much-Anticipated Nvidia Earnings, Anthropic IPO: SLS, BABA, JPM, OMER In Focus
ChartMill
·
10 саат мурун
S&P 500 Top Movers: Gainers and Losers for Nov. 16, 2026
The Motley Fool
·
14 саат мурун
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
Traders Union
·
7 саат мурун
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 миң
Founded1981-ж., 16-апр.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteemcure.com